pentobarbital will decrease the extent or outcome of diclofenac by impacting hepatic enzyme CYP2C9/ten metabolism. Small/Importance Mysterious.
pentobarbital will reduce the level or effect of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unidentified.
pentobarbital will minimize the level or result of voriconazole by influencing hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Unidentified.
Contraindicated. CYP3A4 is answerable for the development and elimination of cariprazine's active metabolites. The effect of CYP3A4 inducers on cariprazine publicity has not been evaluated plus the net outcome is unclear.
pentobarbital will reduce the extent or outcome of parecoxib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will decrease the level or influence of vincristine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.
With therapeutic doses of TCAs, barbiturates boost metabolism and decrease blood concentrations of TCAs.
pentobarbital will lessen the extent or effect of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not advisable; solid cytochrome P450 enzyme inducers minimize systemic publicity to roflumilast and may reduce the therapeutic usefulness
pentobarbital will decrease the level or result of cevimeline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
pentobarbital will lower the extent or effect of methylprednisolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lessen the extent or outcome of zaleplon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.
Drugs that involve prior authorization. This restriction calls for that particular scientific requirements be achieved just before the acceptance on the prescription.
pentobarbital will reduce the extent or effect of ixabepilone by influencing hepatic/intestinal here enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the extent or effect of buprenorphine, long-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Individuals who transfer to buprenorphine extended-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers must be monitored to be sure buprenorphine plasma degrees are enough.